Keebeck Alpha, LP Nevro Corp Transaction History

Keebeck Alpha, LP

  • $150 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$7.96 - $13.59 $199,366 - $340,375
25,046 New
25,046 $210,000
Q3 2022

Nov 07, 2022
BUY
$40.66 - $53.03 $193,094 - $251,839
4,749 New
4,749 $221,000
Q3 2020

Nov 02, 2020
SELL
$114.09 - $145.51 $359,953 - $459,084
-3,155 Closed
0 $0
Q2 2020

Aug 06, 2020
BUY
$89.45 - $129.85 $282,214 - $409,676
3,155 New
3,155 $377,000

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email